Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

REGN

REGENERON PHARMACEUTICALS, INC.

CIK 0000872589 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$667.95
↑ 5.07 (0.76%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Options

Key stats

Market Cap
$62.76B
P/E Ratio
14.19
EPS
43.07
Dividend Yield
0.5%
52W Position
45%
Beta
0.42

Valuation multiples

Fwd P/E
14.58
PEG
1.13
P/B
2.00
P/S
4.21
EV/Revenue
4.14
ROE
14.1%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 45%
$541.00$821.11

Latest Financials

2025-12-31 FY
Revenue
$14.34B
Net Income
$4.50B
Total Assets
$40.56B
Free Cash Flow
–

Recent news